Vantage Financial Partners, LLC Novo Nordisk A S Transaction History

Vantage Financial Partners, LLC

  • $385 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
BUY
$103.24 - $121.81 $2,581 - $3,045
25 Added 0.63%
4,025 $449,000
Q1 2022

May 16, 2022
BUY
$93.1 - $112.54 $186,200 - $225,080
2,000 Added 100.0%
4,000 $444,000
Q4 2021

Mar 03, 2022
BUY
$95.88 - $117.08 $191,760 - $234,160
2,000 New
2,000 $224,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Vantage Financial Partners, LLC Portfolio

Follow Vantage Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email